These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10714216)

  • 1. [Novel mutation-specific monoclonal E-cadherin antibodies make possible allele differentiation at the protein level in tumors].
    Becker I; Becker KF; Kremmer E; Eulitz M; Handschuh G; Höfler H
    Verh Dtsch Ges Pathol; 1999; 83():233-9. PubMed ID: 10714216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional allelic loss detected at the protein level in archival human tumours using allele-specific E-cadherin monoclonal antibodies.
    Becker KF; Kremmer E; Eulitz M; Schulz S; Mages J; Handschuh G; Wheelock MJ; Cleton-Jansen AM; Höfler H; Becker I
    J Pathol; 2002 Aug; 197(5):567-74. PubMed ID: 12210074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of E-cadherin in diffuse-type gastric cancer using a mutation-specific monoclonal antibody.
    Becker KF; Kremmer E; Eulitz M; Becker I; Handschuh G; Schuhmacher C; Müller W; Gabbert HE; Ochiai A; Hirohashi S; Höfler H
    Am J Pathol; 1999 Dec; 155(6):1803-9. PubMed ID: 10595908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diffuse stomach carcinoma: from H&E diagnosis and molecular pathology to specific therapy].
    Höfler H
    Verh Dtsch Ges Pathol; 1999; 83():148-54. PubMed ID: 10714205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly specific tumor binding of a 213Bi-labeled monoclonal antibody against mutant E-cadherin suggests its usefulness for locoregional alpha-radioimmunotherapy of diffuse-type gastric cancer.
    Senekowitsch-Schmidtke R; Schuhmacher C; Becker KF; Nikula TK; Seidl C; Becker I; Miederer M; Apostolidis C; Adam C; Huber R; Kremmer E; Fischer K; Schwaiger M
    Cancer Res; 2001 Apr; 61(7):2804-8. PubMed ID: 11306447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour-associated E-cadherin mutations alter cellular morphology, decrease cellular adhesion and increase cellular motility.
    Handschuh G; Candidus S; Luber B; Reich U; Schott C; Oswald S; Becke H; Hutzler P; Birchmeier W; Höfler H; Becker KF
    Oncogene; 1999 Jul; 18(30):4301-12. PubMed ID: 10439038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor specificity and in vivo targeting of an antibody against exon 9 deleted E-cadherin in gastric cancer.
    Lee HJ; Lee HS; Hur K; Kim WH; Yanagihara K; Becker KF; Lee KU; Yang HK
    J Cancer Res Clin Oncol; 2007 Dec; 133(12):987-94. PubMed ID: 17576594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E-cadherin expression in sporadic gastric cancer from Mexico: exon 8 and 9 deletions are infrequent events associated with poor survival.
    Gamboa-Dominguez A; Dominguez-Fonseca C; Chavarri-Guerra Y; Vargas R; Reyes-Gutierrez E; Green D; Quintanilla-Martinez L; Luber B; Busch R; Becker KF; Becker I; Höfler H; Fend F
    Hum Pathol; 2005 Jan; 36(1):29-35. PubMed ID: 15712179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations.
    Bremm A; Walch A; Fuchs M; Mages J; Duyster J; Keller G; Hermannstädter C; Becker KF; Rauser S; Langer R; von Weyhern CH; Höfler H; Luber B
    Cancer Res; 2008 Feb; 68(3):707-14. PubMed ID: 18245470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer.
    Ascaño JJ; Frierson H; Moskaluk CA; Harper JC; Roviello F; Jackson CE; El-Rifai W; Vindigni C; Tosi P; Powell SM
    Mod Pathol; 2001 Oct; 14(10):942-9. PubMed ID: 11598162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of the human E-cadherin (CDH1) gene.
    Berx G; Becker KF; Höfler H; van Roy F
    Hum Mutat; 1998; 12(4):226-37. PubMed ID: 9744472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of tumor-associated E-cadherin mutations on tumorigenicity and metastasis.
    Kremer M; Quintanilla-Martinez L; Fuchs M; Gamboa-Dominguez A; Haye S; Kalthoff H; Rosivatz E; Hermannstädter C; Busch R; Höfler H; Luber B
    Carcinogenesis; 2003 Dec; 24(12):1879-86. PubMed ID: 12949051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of eleven novel tumor-associated E-cadherin mutations. Mutations in brief no. 215. Online.
    Becker KF; Reich U; Schott C; Becker I; Berx G; van Roy F; Höfler H
    Hum Mutat; 1999; 13(2):171. PubMed ID: 10094558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tumor-associated mutant E-cadherin variants with defects in exons 8 or 9 on matrix metalloproteinase 3.
    Fuchs M; Hermannstädter C; Specht K; Knyazev P; Ullrich A; Rosivatz E; Busch R; Hutzler P; Höfler H; Luber B
    J Cell Physiol; 2005 Mar; 202(3):805-13. PubMed ID: 15389640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E-cadherin gene mutations provide a genetic basis for the phenotypic divergence of mixed gastric carcinomas.
    Machado JC; Soares P; Carneiro F; Rocha A; Beck S; Blin N; Berx G; Sobrinho-Simões M
    Lab Invest; 1999 Apr; 79(4):459-65. PubMed ID: 10211998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma.
    Li Z; Ren Y; Lin SX; Liang YJ; Liang HZ
    Chin Med J (Engl); 2004 Aug; 117(8):1232-9. PubMed ID: 15361301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rac1 and Rho contribute to the migratory and invasive phenotype associated with somatic E-cadherin mutation.
    Deplazes J; Fuchs M; Rauser S; Genth H; Lengyel E; Busch R; Luber B
    Hum Mol Genet; 2009 Oct; 18(19):3632-44. PubMed ID: 19584084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an Italian family.
    Roviello F; Corso G; Pedrazzani C; Marrelli D; De Falco G; Berardi A; Garosi L; Suriano G; Vindigni C; De Stefano A; Leoncini L; Seruca R; Pinto E
    Eur J Surg Oncol; 2007 May; 33(4):448-51. PubMed ID: 17126523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-cadherin germline missense mutations and cell phenotype: evidence for the independence of cell invasion on the motile capabilities of the cells.
    Suriano G; Oliveira MJ; Huntsman D; Mateus AR; Ferreira P; Casares F; Oliveira C; Carneiro F; Machado JC; Mareel M; Seruca R
    Hum Mol Genet; 2003 Nov; 12(22):3007-16. PubMed ID: 14500541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric cancer: new genetic developments.
    Lynch HT; Grady W; Suriano G; Huntsman D
    J Surg Oncol; 2005 Jun; 90(3):114-33; discussion 133. PubMed ID: 15895459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.